Table 3.
miRNA | Expected target | Category | Reference |
---|---|---|---|
miR-221/222 | ETS1/2, irf2, BCL2L1, TOX, BMF, CXCL12 | Activation of CVB3 | [84] |
miR-203 | ZFP-148 | Cell survival | [1] |
miR-141 | eIF4E | Viral translation/cellular translation | [102] |
miR-10a* | CVB3 nt6818-6941 | Viral biosynthesis | [103, 104] |
miR-21 | YOD1, VCL | Desmin/desmosome/cadherin | [79] |
miR-1 | Connection-43 | Gap junction | [105] |
miR-126 | LRP6, WRCH1 | Cell death | [106] |
miR-155 | PU.1 | Inflammation, virus replication | [76, 85] |
miR-146b | IRAK1, TRAF6 | Inflammation | [79, 107] |
miR-142 | MBD2, SOCS1 | Immuno-metabolic turbulence | [108] |
miR-590 | NF-κB/p50 subunit | Inflammation | [80] |
mmu-miR-721/has-miR-Chr8:96 | Pparγ, Nos2, Stat3, Tgfβ, and Cd69 | Early response | [86] |
CVB3, coxsackievirus B3; miRNA, microRNA.